# International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry

> **NCT01464606** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospitals and Clinics of Minnesota** · enrollment: 156 (actual)

## Conditions studied

- Pleuropulmonary Blastoma

## Interventions

- **DRUG:** Vincristine
- **DRUG:** Dactinomycin
- **DRUG:** Cyclophosphamide
- **DRUG:** Ifosfamide
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT01464606
- **Lead sponsor:** Children's Hospitals and Clinics of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2009-12-22
- **Primary completion:** 2025-12
- **Final completion:** 2028-12
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464606, "International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01464606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*